lum_umbsop poster

1
Your name | Teacher’s name | School Purpose Recent studies have shown cell- penetrable lysine dendrimers as promising carriers for targeted anti- cancer drug delivery due to their unique internalization mechanism and biodegradability [1]. In this project, the internalization of dendrimer-doxorubicin conjugates was visualized through confocal microscopy. Introduction Experimental Methods References Results & Discussions Conclusions Acknowledgement Cellular Internalization of G3 Pegylated Poly- L-Lysine Dendrimer with Doxorubicin Joanna Lum 1 , Yewon Pak 2 , Peter W. Swaan 2 1. UMBC, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250 2. Department of Pharmaceutical Sciences, Bio- and Nanotechnology Center, University of Maryland, Baltimore, MD 21201 VISUALIZATION OF G3 PLL-DOX UPTAKE Confocal laser scanning microscopy of MCF-7 cells after incubation with free-DOX (a, b, c), G3 PLL_DOX nanoparticles (d, e ,f). The scale bars correspond to 25 μm in all images. Cytotoxicity of free-DOX and G3 PLL-DOX Doxorubicin (DOX) is an anti- cancer drug that exerts its function by inhibiting the progression of the enzyme topoisomerase II, which relaxes supercoils in DNA for transcription. The penetration into cancer cells is usually limited due to drug resistance and low circulating half-life of chemotherapeutic drugs [2]. Targeted drug delivery can improve drug efficacy and minimize undesired side effects. Dendrimers are favored over traditional linear polymers because of their: Biodegradability Branched structure which facilitates endocytosis Lower toxicity PLL dendrimer, shown in figure 1, was synthesized by reacting L- Lysine methyl ester with ONP-Lys- (BOC) 2 through a process of deprotection and addition by previous work of graduate student, Yewon Pak. CELL CULTURE Breast Cancer MCF-7 cell line was obtained and cultured in media supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and streptomycin in a humidified incubator with 5% CO 2 at 37 o C. CYTOTOXICITY ASSAY The cellular toxicity of free doxorubicin and lysine-doxorubicin conjugates was determined by measuring the inhibition of cell growth using a WST-1 assay. The percentage cell viability was then determined. CONFOCAL LASER SCANNING MICROSCOPY (CLSM) STUDY MCF-7 cells were seeded onto clean and sterile coverslips placed in a 4- chamber slide at an initial density of 2 x 10 5 cells/well and cultured overnight. The cells were then treated with free-DOX and Lysine-DOX conjugates for 4 and 8 hours (equivalent DOX concentration: 30 μg/ml), respectively. After incubation, the cells were fixed, stained and observed by a confocal microscope. Fig. 3: Confocal laser scanning microscopy of MCF-7 cells after incubation with HBSS buffer (A,B) free-DOX (C, D), G3 PLL-DOX nanoparticles (E,F). All cells were fluorescently stained with DAPI. G3 Pegylated PLL Dendrimer-DOX showed greater inhibition at lower concentrations in MCF-7 cells relative to free DOX G3 Pegylated PLL Dendrimer-DOX was endocytosed into small and punctate vesicles. The vesicles were shown to traffic towards the nucleus where they could eventually inhibit DNA replication of tumor cells. Poly-L-Lysine dendrimer can be used a prospective vehicle for sustained drug release targeted to cancer cells. [1] Zhao, J., Zhou, R., Fu, X., Ren, W., Ma, L., Li, R., Zhao, Y., Guo, L. (2000). Cell-penetrable lysine dendrimers for anti-cancer drug delivery: synthesis and preliminary biological evaluation. AAPS PharmSciTech. [2] Sun, Y., Zhang, J., Han, J., Tian, B., Shi, Y., Ding, Y., . . . Han, J. (2016). Galactose-Containing Polymer-DOX Conjugates for Targeting Drug Delivery. AAPS PharmSciTech. Fig. 2: The half maximal inhibitory concentrations (IC50) showed the effectiveness of G3 PLL-DOX and DOX with increasing concentration. This measurement indicated that 1.30 μM of DOX was needed, while only 0.87 μM G3 PLL-DOX was needed to achieve the same level of inhibition. Fig. 1: Final Structure of G3 Pegylated PLL Dendrimer with DOX IC50: 0.87μM IC50: 1.30μM This work was supported by a funding from the UMBC Office of Academic and Pre-Professional Advising, and a UMB- UMBC partnership. 4 h 6 h DOX HBSS G3 PLL-DOX A F E D C B

Upload: joanna-lum

Post on 15-Apr-2017

32 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Lum_UMBSOP Poster

Your name | Teacher’s name | School

Purpose

Recent studies have shown cell-penetrable lysine dendrimers as promising carriers for targeted anti-cancer drug delivery due to their unique internalization mechanism and biodegradability [1]. In this project, the internalization of dendrimer-doxorubicin conjugates was visualized through confocal microscopy.

Introduction

Experimental Methods

References

Results & Discussions

Conclusions

Acknowledgement

 

Cellular Internalization of G3 Pegylated Poly-L-Lysine Dendrimer with Doxorubicin

Joanna Lum1, Yewon Pak2, Peter W. Swaan21. UMBC, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250

2. Department of Pharmaceutical Sciences, Bio- and Nanotechnology Center, University of Maryland, Baltimore, MD 21201

VISUALIZATION OF G3 PLL-DOX UPTAKE

Confocal laser scanning microscopy of MCF-7 cells after incubation with free-DOX (a, b, c), G3 PLL_DOX nanoparticles (d, e ,f). The scale bars correspond to 25 μm in all images.

Cytotoxicity of free-DOX and G3 PLL-DOX

• Doxorubicin (DOX) is an anti-cancer drug that exerts its function by inhibiting the progression of the enzyme topoisomerase II, which relaxes supercoils in DNA for transcription.

• The penetration into cancer cells is usually limited due to drug resistance and low circulating half-life of chemotherapeutic drugs [2].

• Targeted drug delivery can improve drug efficacy and minimize undesired side effects.

• Dendrimers are favored over traditional linear polymers because of their:• Biodegradability• Branched structure which facilitates

endocytosis• Lower toxicity

• PLL dendrimer, shown in figure 1, was synthesized by reacting L-Lysine methyl ester with ONP-Lys-(BOC)2 through a process of deprotection and addition by previous work of graduate student, Yewon Pak.

CELL CULTUREBreast Cancer MCF-7 cell line was obtained and cultured in media supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and streptomycin in a humidified incubator with 5% CO2 at 37oC.CYTOTOXICITY ASSAYThe cellular toxicity of free doxorubicin and lysine-doxorubicin conjugates was determined by measuring the inhibition of cell growth using a WST-1 assay. The percentage cell viability was then determined.CONFOCAL LASER SCANNING MICROSCOPY (CLSM) STUDY MCF-7 cells were seeded onto clean and sterile coverslips placed in a 4-chamber slide at an initial density of 2 x 105 cells/well and cultured overnight. The cells were then treated with free-DOX and Lysine-DOX conjugates for 4 and 8 hours (equivalent DOX concentration: 30 μg/ml), respectively. After incubation, the cells were fixed, stained and observed by a confocal microscope.

Fig. 3: Confocal laser scanning microscopy of MCF-7 cells after incubation with HBSS buffer (A,B) free-DOX (C, D), G3 PLL-DOX nanoparticles (E,F). All cells were fluorescently stained with DAPI.

• G3 Pegylated PLL Dendrimer-DOX showed greater inhibition at lower concentrations in MCF-7 cells relative to free DOX

• G3 Pegylated PLL Dendrimer-DOX was endocytosed into small and punctate vesicles. The vesicles were shown to traffic towards the nucleus where they could eventually inhibit DNA replication of tumor cells.

• Poly-L-Lysine dendrimer can be used a prospective vehicle for sustained drug release targeted to cancer cells.

[1] Zhao, J., Zhou, R., Fu, X., Ren, W., Ma, L., Li, R., Zhao, Y., Guo, L. (2000). Cell-penetrable lysine dendrimers for anti-cancer drug delivery: synthesis and preliminary biological evaluation. AAPS PharmSciTech. [2] Sun, Y., Zhang, J., Han, J., Tian, B., Shi, Y., Ding, Y., . . . Han, J. (2016). Galactose-Containing Polymer-DOX Conjugates for Targeting Drug Delivery. AAPS PharmSciTech.

• Fig. 2: The half maximal inhibitory concentrations (IC50) showed the effectiveness of G3 PLL-DOX and DOX with increasing concentration. This measurement indicated that 1.30 μM of DOX was needed, while only 0.87 μM G3 PLL-DOX was needed to achieve the same level of inhibition.

• Fig. 1: Final Structure of G3 Pegylated PLL Dendrimer with DOX

IC50: 0.87μM IC50: 1.30μM

This work was supported by a funding from the UMBC Office of Academic and Pre-Professional Advising, and a UMB-UMBC partnership.

4 h

6 h

DOXHBSS G3 PLL-DOX

A

F

E

D

C

B